EDSA — Edesa Biotech Balance Sheet
0.000.00%
Last trade - 00:00- $14.36m
- $13.78m
Annual balance sheet for Edesa Biotech, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | 2024 September 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 7.21 | 7.84 | 7.09 | 5.36 | 1.04 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.087 | 3.3 | 1.26 | 0.627 | 0.271 |
| Prepaid Expenses | |||||
| Total Current Assets | 8.1 | 12.1 | 9.09 | 6.44 | 1.68 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.175 | 0.112 | 0.031 | 0.1 | 0.018 |
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 10.8 | 14.6 | 11.6 | 8.89 | 3.81 |
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Current Liabilities | 1.53 | 1.46 | 2.14 | 1.82 | 1.83 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 1.65 | 1.53 | 2.18 | 1.84 | 1.83 |
| Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 9.11 | 13.1 | 9.39 | 7.05 | 1.98 |
| Total Liabilities & Shareholders' Equity | 10.8 | 14.6 | 11.6 | 8.89 | 3.81 |
| Total Common Shares Outstanding |